ANGO vs SRPT · rev $292.5M vs rev $1.90B
AngioDynamics Inc (ANGO) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
ANGO currently screens at market cap $378.5M. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the ANGO and SRPT stock pages for the full models.
Not investment advice.